# Vaccination With Tetanus and KLH to Assess Immune Responses.

> **NCT00000105** · — · TERMINATED · sponsor: **Masonic Cancer Center, University of Minnesota** · enrollment: 112 (actual)

## Conditions studied

- Cancer

## Interventions

- **BIOLOGICAL:** Intracel KLH Vaccine
- **BIOLOGICAL:** Biosyn KLH
- **DRUG:** Montanide ISA51
- **BIOLOGICAL:** Tetanus toxoid

## Key facts

- **NCT ID:** NCT00000105
- **Lead sponsor:** Masonic Cancer Center, University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2002-07
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 112 (ACTUAL)
- **Why stopped:** Replaced by another study.
- **Last updated:** 2017-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000105, "Vaccination With Tetanus and KLH to Assess Immune Responses.". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT00000105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*